From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer

被引:60
作者
Didiasova, Miroslava [1 ]
Wujak, Lukasz [1 ]
Wygrecka, Malgorzata [1 ,2 ]
Zakrzewicz, Dariusz [1 ]
机构
[1] Univ Giessen, Dept Biochem, Fac Med, Lung Ctr, D-35392 Giessen, Germany
[2] German Ctr Lung Res, D-35392 Giessen, Germany
关键词
actin; annexin; 2; cytokeratin-8; enolase-1; plasmin; plasminogen; plasminogen receptor; CELL LUNG-CANCER; ANNEXIN A2 HETEROTETRAMER; ALPHA-ENOLASE; BREAST-CANCER; TUMOR-GROWTH; BETA-ACTIN; PANCREATIC-CANCER; CARCINOMA-CELLS; CYTOKERATIN; GLYCOLYTIC-ENZYMES;
D O I
10.3390/ijms151121229
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell surface-associated proteolysis mediated by plasmin (PLA) is an essential feature of wound healing, angiogenesis and cell invasion, processes that are dysregulated in cancer development, progression and systemic spread. The generation of PLA, initiated by the binding of its precursor plasminogen (PLG) to the cell surface, is regulated by an array of activators, inhibitors and receptors. In this review, we will highlight the importance of the best-characterized components of the PLG/PLA cascade in the pathogenesis of cancer focusing on the role of the cell surface-PLG receptors (PLG-R). PLG-R overexpression has been associated with poor prognosis of cancer patients and resistance to chemotherapy. We will also discuss recent findings on the molecular mechanisms regulating cell surface expression and distribution of PLG-R.
引用
收藏
页码:21229 / 21252
页数:24
相关论文
共 148 条
[1]   Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes [J].
Altenberg, B ;
Greulich, KO .
GENOMICS, 2004, 84 (06) :1014-1020
[2]   Evolving role of uPA/uPAR system in human cancers [J].
Ass, Kathleen ;
Ahmad, Aamir ;
Azmi, Asfar S. ;
Sarkar, Sarah H. ;
Sarkar, Fazlul H. .
CANCER TREATMENT REVIEWS, 2008, 34 (02) :122-136
[3]   Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer [J].
Azios, NG ;
Dharmawardhane, SF .
NEOPLASIA, 2005, 7 (02) :128-140
[4]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[5]   Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA [J].
Abhijit G Banerjee ;
Jie Liu ;
Yawei Yuan ;
Velliyur K Gopalakrishnan ;
Sonny L Johansson ;
Amit K Dinda ;
Narmada P Gupta ;
Lindsey Trevino ;
Jamboor K Vishwanatha .
Molecular Cancer, 2 (1)
[6]   Urokinase system expression in gastric carcinoma - Prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens [J].
Beyer, BCM ;
Heiss, MM ;
Simon, EH ;
Gruetzner, KU ;
Babic, R ;
Jauch, KW ;
Schildberg, FW ;
Allgayer, H .
CANCER, 2006, 106 (05) :1026-1035
[7]   Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma [J].
Brattström, D ;
Wagenius, G ;
Sandström, P ;
Dreilich, M ;
Bergström, S ;
Goike, H ;
Hesselius, P ;
Bergqvist, M .
DISEASES OF THE ESOPHAGUS, 2005, 18 (05) :298-303
[8]  
Bugge TH, 1997, BLOOD, V90, P4522
[9]   The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and Janus kinase (JAK)/STAT signaling pathways [J].
Burysek, L ;
Syrovets, T ;
Simmet, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (36) :33509-33517
[10]   α-enolase: a promising therapeutic and diagnostic tumor target [J].
Capello, Michela ;
Ferri-Borgogno, Sammy ;
Cappello, Paola ;
Novelli, Francesco .
FEBS JOURNAL, 2011, 278 (07) :1064-1074